Xiao-Yan He
Biographic Data
| ID | 7265365 |
|---|---|
| NAME | Xiao-Yan He |
| GIVEN NAMES | Xiao-Yan |
| FAMILY NAME | He |
| SIGNATURE | HE X |
| AFFILIATIONS | Chengdu University of Traditional Chinese Medicine |
| ORCID | 0000-0003-4872-3139 |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Cognitive impairment across the schizophrenia spectrum
These findings support a stratified continuum of cognitive impairment across schizophrenia progression. While chronic patients manifest generalized deficits, at-risk populations demonstrate distinct profiles: FDR display subclinical vulnerabilities, whereas CHR show intermediate impairment exceeding familial risk but preceding acute psychosis. The differential trajectory of verbal memory and executive function deficits from FEP to MECS suggests p…
Dahuang zhechong pill ameliorates hepatic fibrosis by regulating gut microbiota and metabolites
Risk factors for violent behaviors in patients with schizophrenia
Risk evaluation, prevention and management of violence in patients with schizophrenia are demanded in primary mental health care
Quality of life in patients with schizophrenia
Objective: Quality of life (QoL) has been always an important way to evaluate the outcomes of schizophrenia, but there have been few previous longitudinal studies and few in middle-income countries. This study aimed to explore the QoL in Chinese patients with schizophrenia treated in primary mental health care and the risk factors of QoL over time. Methods: Patients with schizophrenia treated in primary mental health care in rural/regional areas …
Amygdalin - A pharmacological and toxicological review
No prominent works on this page.
Amygdalin - A pharmacological and toxicological review
Quality of life in patients with schizophrenia
Objective: Quality of life (QoL) has been always an important way to evaluate the outcomes of schizophrenia, but there have been few previous longitudinal studies and few in middle-income countries. This study aimed to explore the QoL in Chinese patients with schizophrenia treated in primary mental health care and the risk factors of QoL over time. Methods: Patients with schizophrenia treated in primary mental health care in rural/regional areas …
Risk factors for violent behaviors in patients with schizophrenia
Risk evaluation, prevention and management of violence in patients with schizophrenia are demanded in primary mental health care
Dahuang zhechong pill ameliorates hepatic fibrosis by regulating gut microbiota and metabolites
Cognitive impairment across the schizophrenia spectrum
These findings support a stratified continuum of cognitive impairment across schizophrenia progression. While chronic patients manifest generalized deficits, at-risk populations demonstrate distinct profiles: FDR display subclinical vulnerabilities, whereas CHR show intermediate impairment exceeding familial risk but preceding acute psychosis. The differential trajectory of verbal memory and executive function deficits from FEP to MECS suggests p…
Medicine (5 works) · Psychiatry (3 works) · Schizophrenia research and treatment (3 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Gee (2 works) · Generalized estimating equation (2 works) · Internal Medicine (2 works) · Mental health (2 works) · Mental Health Treatment and Access (2 works)